We carried out a post hoc analysis of a double-blind trial in which patients aged 18 years with bipolar I disorder ( DSM-IV ) who had achieved stabilization from a manic , depressive , or mixed episode during open-label treatment with quetiapine were randomized to continue quetiapine or to switch to lithium or placebo for up to 104 weeks .
